Molekulares Profil im Visier
- 25 November 2013
- journal article
- Published by Springer Science and Business Media LLC in Info Onkologie
- Vol. 16 (7), 38-41
- https://doi.org/10.1007/s15004-013-0639-3
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Biomarkers in Breast Cancer – An UpdateGeburtshilfe und Frauenheilkunde, 2012
- Pertuzumab: new hope for patients with HER2-positive breast cancerAnnals of Oncology, 2012
- Personalized Medicine: The Road AheadClinical Breast Cancer, 2011
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialThe Lancet Oncology, 2010
- Use of Archived Specimens in Evaluation of Prognostic and Predictive BiomarkersJNCI Journal of the National Cancer Institute, 2009
- Trastuzumab: triumphs and tribulationsOncogene, 2007
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Proliferation Marker Ki-67 in Early Breast CancerJournal of Clinical Oncology, 2005
- Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trialThe Journal of Pathology, 2002
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987